Study Stopped
terminated due to failure to enroll patients after two years of approval
Ischemic Conditioning (Delay Phenomenon) in Colorectal Surgery
1 other identifier
interventional
10
1 country
1
Brief Summary
One of the major complications of surgical excision of colorectal cancer includes improper healing of the anastomosis (reconnection of the remaining, cancer free intestine). This can result in anastomotic leak, abscess then abdominal and/or pelvic sepsis and mortality. Esophageal surgery has suffered from complications. Recently, an innovation in esophageal surgery has seen a relatively drastic decrease in complications during distal esophagectomies using a technique called "ischemic conditioning". This technique involves dividing the blood supply to the stomach that would be performed during a 1-stage esophagectomy but returning days later to complete the resection. Bench results have shown improved angiogenesis, vasodilation, less anastomotic collagen deposition and minimized ischemia at the time of surgery while clinical results have included improved stricture rates, leak rates and mortality in esophageal surgery. Hypothesis Ischemic conditioning is universal to the intestinal tract and a similar technique can be applied in colon and rectal surgery. The investigators plan evaluating this hypothesis by performing a pilot study comprised of the following: performing an endovascular embolization of the inferior mesenteric artery (IMA) followed by interval laparoscopic or open rectosigmoid resection. Methods Part 1 - Endovascular Procedure Patients will be admitted and undergo endovascular embolization of their IMA as an outpatient following diagnostic angiography. They will undergo sigmoidoscopy throughout the embolization and a laser probe will indirectly measure tissue oxygenation. The patient will be released home that day. Part 2 - Colorectal Procedure Patients will then return 2-4 days later for their definitive laparoscopic or open rectosigmoid resection. They will undergo sigmoidoscopy before and after surgery and a laser probe will indirectly measure tissue oxygenation. The patient will then be released home on average 3-5 days later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Apr 2009
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 22, 2009
CompletedFirst Posted
Study publicly available on registry
April 24, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedSeptember 28, 2011
September 1, 2011
2.2 years
April 22, 2009
September 26, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Any adverse even (safety study)
6-12 months
Study Arms (1)
Catheterization
EXPERIMENTALPatients receive angioembolization prior to surgery
Interventions
Eligibility Criteria
You may qualify if:
- Are at least 18 years of age, male or female
- Are scheduled for a non-emergent, resection of your colon
- Are able to give written informed consent to indicate an understanding of the study procedures.
You may not qualify if:
- Will be undergoing an emergency procedure or has a diagnosis of bowel complication(s) such as bowel obstruction, constriction, inflammation, infection, or have inflammatory bowel disease.
- Are currently participating in another clinical trial which may affect this study's outcomes.
- Have been taking regular steroid medication.
- Have a negative reaction to general anesthesia.
- Have severe arterial occlusive disease (disease of the blood vessels affecting blood flow to your legs).
- Have an abdominal aortic aneurysm (dilation of the large artery in your abdomen).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Irvine Medical Center
Orange, California, 92868, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Steven D Mills, MD
University of California, Irvine
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2009
First Posted
April 24, 2009
Study Start
April 1, 2009
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
September 28, 2011
Record last verified: 2011-09